Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinshen granules for stable angina (phase II)
CTR20140053Phase 2Active
- Sponsor
- Yusen Pharma
- Start
- Mar 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Yinshen Granules in coronary arteriosclerosis, angina pectoris, sponsored by Yusen Pharma. Started Mar 2014; status: active.
02
Drugs
Yinshen Granules
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20140053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140053.